Editorial & Columns Exchange Rate Fluctuations : Effects on Pharmaceutical Sector in SAARC Nations May 29, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Inflation and Pharmaceutical Products: A Global Concern May 22, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Skin in the Game: Promoter Holding in Indian Pharmaceutical Companies May 15, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns India-Australia Economic Cooperation and Trade Agreement & Pharmaceutical Exports from India May 9, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Prescription for Segment Reporting by Pharmaceutical Companies in India April 13, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Private Equity and Indian Pharmaceutical Industry- A Review March 7, 2024 | Dr. Anil Kumar Angrish | No Comments | More